Diaz-Cruz ES - Search Results

1

BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.

Diaz-Cruz ES, Cabrera MC, Nakles R, Rutstein BH, Furth PA. Diaz-Cruz ES, et al. Breast Dis. 2010;32(1-2):85-97. doi: 10.3233/BD-2010-0308. Breast Dis. 2010. PMID: 21778574 Free PMC article. Review.

2

Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.

Furth PA, Nakles RE, Millman S, Diaz-Cruz ES, Cabrera MC. Furth PA, et al. Breast Cancer Res. 2011 Oct 12;13(5):220. doi: 10.1186/bcr2921. Breast Cancer Res. 2011. PMID: 22018398 Free PMC article. Review.

3

Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.

Díaz-Cruz ES, Furth PA. Díaz-Cruz ES, et al. Cancer Res. 2010 May 15;70(10):3965-74. doi: 10.1158/0008-5472.CAN-09-3450. Cancer Res. 2010. PMID: 20466998 Free PMC article.

4

Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.

Nakles RE, Shiffert MT, Díaz-Cruz ES, Cabrera MC, Alotaiby M, Miermont AM, Riegel AT, Furth PA. Nakles RE, et al. Mol Endocrinol. 2011 Apr;25(4):549-63. doi: 10.1210/me.2010-0114. Epub 2011 Feb 3. Mol Endocrinol. 2011. PMID: 21292825 Free PMC article.

5

Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.

Furth PA, Cabrera MC, Díaz-Cruz ES, Millman S, Nakles RE. Furth PA, et al. Ann N Y Acad Sci. 2011 Jul;1229(1):147-55. doi: 10.1111/j.1749-6632.2011.06086.x. Ann N Y Acad Sci. 2011. PMID: 21793850 Free PMC article. Review.

6

Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.

Díaz-Cruz ES, Sugimoto Y, Gallicano GI, Brueggemeier RW, Furth PA. Díaz-Cruz ES, et al. Cancer Res. 2011 Aug 15;71(16):5477-87. doi: 10.1158/0008-5472.CAN-10-4652. Cancer Res. 2011. PMID: 21840986 Free PMC article.

7

The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway.

Cabrera MC, Díaz-Cruz ES, Kallakury BV, Pishvaian MJ, Grubbs CJ, Muccio DD, Furth PA. Cabrera MC, et al. Cancer Prev Res (Phila). 2012 Jun;5(6):810-21. doi: 10.1158/1940-6207.CAPR-11-0532-T. Epub 2012 Apr 16. Cancer Prev Res (Phila). 2012. PMID: 22508966 Free PMC article.

8

Association of Over-Expressed Estrogen Receptor Alpha with Development of Tamoxifen Resistant Hyperplasia and Adenocarcinomas in Genetically Engineered Mice.

Miermont AM, Cabrera MC, Frech SM, Nakles RE, Diaz-Cruz ES, Shiffert MT, Furth PA. Miermont AM, et al. Among authors: diaz cruz es. Anat Physiol. 2012 Jun 25;Suppl 12:001. doi: 10.4172/2161-0940.s12-001. Anat Physiol. 2012. PMID: 24575359 Free PMC article.

9

Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.

Dabydeen SA, Kang K, Díaz-Cruz ES, Alamri A, Axelrod ML, Bouker KB, Al-Kharboosh R, Clarke R, Hennighausen L, Furth PA. Dabydeen SA, et al. Among authors: diaz cruz es. Carcinogenesis. 2015 Jan;36(1):122-32. doi: 10.1093/carcin/bgu237. Epub 2014 Nov 23. Carcinogenesis. 2015. PMID: 25421723 Free PMC article.

10

Differential efatutazone's impact on mammary neoplasia dependent upon Brca1 dose.

Alothman SJ, Wang W, Chao S, Kallakury BV, Díaz-Cruz ES, Furth PA. Alothman SJ, et al. Among authors: diaz cruz es. Endocr Relat Cancer. 2018 Dec 1;25(12):L53-L57. doi: 10.1530/ERC-18-0299. Endocr Relat Cancer. 2018. PMID: 30400020 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page